These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11079662)

  • 1. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.
    Tsutsui T; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Ohnishi M; Kinoshita M
    J Am Coll Cardiol; 2002 Mar; 39(6):957-62. PubMed ID: 11897436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure.
    Tsutamoto T; Asai S; Tanaka T; Sakai H; Nishiyama K; Fujii M; Yamamoto T; Ohnishi M; Wada A; Saito Y; Horie M
    Eur J Heart Fail; 2007 Oct; 9(10):1032-7. PubMed ID: 17766177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Hisanaga T; Wada A; Maeda K; Ohnishi M; Fukai D; Mabuchi N; Sawaki M; Kinoshita M
    J Am Coll Cardiol; 1998 Feb; 31(2):391-8. PubMed ID: 9462584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Matsui T; Kinoshita M
    J Am Coll Cardiol; 2001 Apr; 37(5):1228-33. PubMed ID: 11300427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.
    Ishii J; Cui W; Kitagawa F; Kuno T; Nakamura Y; Naruse H; Mori Y; Ishikawa T; Nagamura Y; Kondo T; Oshima H; Nomura M; Ezaki K; Hishida H
    Clin Chem; 2003 Dec; 49(12):2020-6. PubMed ID: 14633873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
    Stanek B; Frey B; Hülsmann M; Berger R; Sturm B; Strametz-Juranek J; Bergler-Klein J; Moser P; Bojic A; Hartter E; Pacher R
    J Am Coll Cardiol; 2001 Aug; 38(2):436-42. PubMed ID: 11499735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure.
    Sakai H; Tsutamoto T; Tsutsui T; Tanaka T; Ishikawa C; Horie M
    Circ J; 2006 Aug; 70(8):1006-11. PubMed ID: 16864933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Mar; 35(3):714-21. PubMed ID: 10716475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments--comparison with neurohumoral factors.
    Matsui T; Tsutamoto T; Maeda K; Kusukawa J; Kinoshita M
    Circ J; 2002 Jun; 66(6):537-43. PubMed ID: 12074268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
    Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC
    J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure.
    Tamura K; Takahashi N; Nakatani Y; Onishi S; Iwasaka T
    Gerontology; 2001; 47(1):46-51. PubMed ID: 11244291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.